Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06710080 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia

Study acronym: TIN-CAP
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contact updatedv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 15, 2024 to Apr 8, 2026
    • Site details revised
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if icosapent ethyl (Vascepa) works to lessen the amount of inflammation in adults diagnosed with Community-Acquired Pneumonia (CAP). The main question it aims to answer is: What is the effect of taking Vascepa on inflammation in the arteries in patients with CAP? Researchers will compare the drug Vascepa to a placebo (a look-alike submstance that contains no drug) to see if Vascepa works to reduce inflammation in patients with CAP. Participants wil: * take Vacscepa or a placebo twice a day for 6 months * Visit the clinic 3 times (baseline, 30 days, and 6 months) for checkups and tests
Trial Details
NCT Number NCT06710080
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions
(from sponsor)		 Inflammation, Community Acquired Pneumonia (CAP), Inflammation Plaque, Atherosclerotic
Related terms Community-Acquired Infections, Community-Acquired Pneumonia, Inflammation, Plaque, Atherosclerotic
Enrollment 168 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov